| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
21,849 |
17,841 |
$967K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13,620 |
12,333 |
$651K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,981 |
2,748 |
$254K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,767 |
2,584 |
$254K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,320 |
2,035 |
$203K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,769 |
1,606 |
$161K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
9,656 |
8,793 |
$150K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
11,594 |
10,533 |
$72K |
| 92552 |
|
4,262 |
3,677 |
$66K |
| 97802 |
|
7,555 |
6,718 |
$49K |
| 99401 |
|
3,911 |
3,250 |
$33K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,975 |
2,769 |
$26K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,202 |
1,725 |
$14K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,915 |
1,738 |
$12K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
439 |
396 |
$9K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
710 |
571 |
$6K |
| 99188 |
|
275 |
257 |
$4K |
| 90686 |
|
2,842 |
2,599 |
$4K |
| H0049 |
Alcohol and/or drug screening |
167 |
166 |
$3K |
| 96127 |
|
3,417 |
2,498 |
$3K |
| G0270 |
Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes |
2,081 |
1,897 |
$2K |
| 92567 |
|
277 |
268 |
$2K |
| 99051 |
|
233 |
206 |
$1K |
| 83655 |
|
184 |
163 |
$1K |
| 94760 |
|
7,301 |
5,584 |
$667.00 |
| 96156 |
|
1,586 |
1,334 |
$478.30 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
38 |
38 |
$268.35 |
| 87807 |
|
24 |
24 |
$229.21 |
| 90651 |
|
570 |
510 |
$228.54 |
| 90633 |
|
397 |
347 |
$169.78 |
| 90670 |
|
1,270 |
1,100 |
$130.26 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
2,164 |
1,858 |
$101.20 |
| 81003 |
|
69 |
65 |
$87.85 |
| 90734 |
|
93 |
91 |
$68.02 |
| 99173 |
|
7,495 |
5,622 |
$53.31 |
| S9451 |
Exercise classes, non-physician provider, per session |
9,003 |
6,703 |
$39.15 |
| 81002 |
|
15 |
15 |
$14.24 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
13 |
12 |
$2.08 |
| 90715 |
|
66 |
58 |
$0.03 |
| 90698 |
|
13 |
13 |
$0.01 |
| 90681 |
|
65 |
65 |
$0.01 |
| V5008 |
Hearing screening |
1,497 |
1,434 |
$0.00 |
| 90619 |
|
63 |
59 |
$0.00 |
| 3008F |
|
2,681 |
2,478 |
$0.00 |
| 90647 |
|
162 |
147 |
$0.00 |
| 2001F |
|
2,700 |
2,493 |
$0.00 |
| 96151 |
|
124 |
122 |
$0.00 |
| 99000 |
|
177 |
155 |
$0.00 |
| 90723 |
|
149 |
123 |
$0.00 |
| 90677 |
|
17 |
16 |
$0.00 |
| 90697 |
|
112 |
105 |
$0.00 |
| 90696 |
|
49 |
39 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
66 |
58 |
$0.00 |
| 92551 |
|
15 |
15 |
$0.00 |
| 90710 |
|
32 |
27 |
$0.00 |
| 2014F |
|
123 |
110 |
$0.00 |
| 90700 |
|
14 |
12 |
$0.00 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
20 |
19 |
$0.00 |
| 90671 |
|
12 |
12 |
$0.00 |